Daniel N. Swisher, Jr

2014 - Sunesis Pharmaceuticals

In 2014, Daniel N. Swisher, Jr earned a total compensation of $2.4M as CEO and President at Sunesis Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$202,000
Option Awards$1,736,160
Salary$488,094
Other$3,466
Total$2,429,720

Swisher received $1.7M in option awards, accounting for 71% of the total pay in 2014.

Swisher also received $202K in non-equity incentive plan, $488.1K in salary and $3.5K in other compensation.

Rankings

In 2014, Daniel N. Swisher, Jr's compensation ranked 3,760th out of 13,032 executives tracked by ExecPay. In other words, Swisher earned more than 71.1% of executives.

ClassificationRankingPercentile
All
3,760
out of 13,032
71st
Division
Manufacturing
1,325
out of 4,966
73rd
Major group
Chemicals And Allied Products
430
out of 1,686
75th
Industry group
Drugs
334
out of 1,365
76th
Industry
Pharmaceutical Preparations
269
out of 1,043
74th
Source: SEC filing on April 20, 2017.

Swisher's colleagues

We found one more compensation record of an executive who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2014.

2014

Eric Bjerkholt

Sunesis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like